Drug
Cx11
Cx11: highest development phase Phase 2, developed by Corxel Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Corxel Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| CX11 NCT07340320 | Phase 2 | Type II Diabetes Mellitus |
Latest
No recent events.
Follow Cx11 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.